|
|
Volumn 4, Issue 1, 2005, Pages 3-4
|
|
Editorial: Inflammation, COX-2 inhibitors, and cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ASCORBIC ACID;
CELECOXIB;
CYCLOOXYGENASE 2 INHIBITOR;
IBUPROFEN;
INDOMETACIN;
NAPROXEN;
NONSTEROID ANTIINFLAMMATORY AGENT;
ROFECOXIB;
VALDECOXIB;
PROSTAGLANDIN SYNTHASE INHIBITOR;
ANTINEOPLASTIC ACTIVITY;
BREAST CANCER;
CANCER;
CANCER RISK;
CANCER THERAPY;
CARDIOTOXICITY;
EDITORIAL;
HUMAN;
INFLAMMATION;
PRIORITY JOURNAL;
IMMUNOLOGY;
NEOPLASM;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
CYCLOOXYGENASE INHIBITORS;
HUMANS;
INFLAMMATION;
NEOPLASMS;
|
|
EID: 19444378259
PISSN: 15347354
EISSN: None
Source Type: Journal
DOI: 10.1177/1534735405274664 Document Type: Editorial |
|
Times cited : (6)
|
|
References (3)
|
